Goldplat CEO Werner Klingenberg discusses dividend policy, share buybacks and the Kilimenpesa sale. Watch the full video here.
Yes TEK's stake in BELL is worth around 40% of TEK's market currently...
TEK owns 17.1 million shares in BELL. Current bid price is 70p * 17.1 million = £12 million
Current market cap of TEK = 22p * 130.8 million shares (rounded) = £28.8 million
12 / 28.8 = 41.7%
LONDON, U.K. AND PLANO, TX, U.S. (27 July 2021). Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces it has started manufacturing and has signed its fourth distribution agreement.
The first X-PLO2R™ units are currently being manufactured in the US and the Company expects to meet its targeted commercial launch of X-PLO2R™, with the first units being distributed in Q3 2021.
The Company also recently signed its fourth distribution agreement with a US Service-Disabled Veteran-Owned Small Business dealing exclusively with the US federal government in areas such as Veterans Affairs and The Department of Defense. This is the next stage in establishing US-wide distribution coverage as part of the Company's commercialisation strategy.
As described in the Company's Admission Document, Belluscura's plan is to appoint distributors in the US to give US-wide coverage for the launch of the X-PLO2R™. Following launch in the US, the Company intends to pursue commercialisation globally.
Robert Rauker, CEO of Belluscura plc, said: "The Company has made great progress since X-PLO2R™ received FDA 510(k) clearance in March and the commencement of manufacturing is the next step before our targeted commercial launch this quarter. We have been pleased with the early interest from distributors based in the US, Europe, South America and Asia, wanting to supply the X-PLO2R™, which gives us great confidence for 2021 and beyond. Additionally, having the X-PLO2R™ portable oxygen concentrator available through a Service-Disabled Veteran-Owned Small Business is a tremendous opportunity and great honour for the Company."
Information about the Salarius crowdfunding on the below site and looks like an additional round which was started in June...
Some good Q&As on the above site as well such as the one below...
"I work in various hospitals in Texas (multiple cities) - I have not seen your product in any hospital/healthcare organization in Texas - why ? Being a health oriented product - why is it not on the menus of hospitalized patients (most hospitalized patients are on low sodium diets)? Why is it not in all hospital canteens/cafes ? Why has theSaltMe chips not seeked the backing of AmericanHeartOrganization ??? If available at a hospital for patients who need low sodium alternatives - then the message carries home not just to the patient - but to the rest of the family (customer multiplier effect). If SaltMe chips get backing of American Heart Association - then it s a winner."
Answer from CEO
"Hello. Great questions and suggestions. We are in the process of working on that. We are a young company and we need to ensure we expand with solid steps. As we launch our MicroSalt packs by the end of the year, we have a robust strategy to get to hospitals and their cafes. Also, we are in constant communication with the American Heart Association (I personally met with their team in Washington DC) to develop some synergies for our products or for our customers."
Update from Harrison Gross CEO
To our dear investors,
I'm sending you this update because you were a part of our first crowdfund on Startengine. We are so grateful for your contribution to the company. It enabled us to do incredible things, like bringing the first smart eyewear to market that looks, feels and functions like regular eyeglasses. As we relaunch on Startengine to help continue our rapid growth, I wanted to take a moment to reflect on what we were able to accomplish in just one year thanks to our investors.
-Launched Lucyd Lyte e-glasses in six styles, to a terrific response from our customers. Over 200 5-star reviews have been received. Six new styles of Lyte will launch in the next 60 days, including some models with industry-first titanium frontplates that weigh just 30g, on par with traditional eyeglasses. We believe this will make Lucyd the most expansive line of smart eyewear worldwide.
-Began development of our Vyrb social media app, which we expect to launch this September to enhance our e-glasses with social features.
-Attended the Vision Expo East eyewear show, where we onboarded fifty optical stores as resellers of Lucyd Lyte, and received loads of useful feedback from optical professionals.
-Secured a national Canadian distribution deal with Marca Eyewear, who committed to buying over $4m of our eyewear from us over 30 months. Read the release on Yahoo! Finance.
-Built a full sales team including a 30-year eyewear industry veteran as head of sales, and a successful fitness tech sales director.
-Signed a partnership deal with D Landstrom Associates to aggressively pursue placement of Lucyd Lyte in big box stores.
-A number of key sporting goods and electronics retailers are currently evaluating Lucyd Lyte for inclusion in their stores.
-We were granted our first utility patent for a software application to manage wearables and IOT devices.
Snapshot of the six upcoming Lucyd Lyte™ styles, launching this September.
As exciting as our progress so far has been, it is difficult to express how thrilled our team is for the future. In just one year, we took the company from a humble startup to a fully-fledged wearables corporation. In light of this terrific growth, I would like to invite you to further build your position in our pioneering wearables company. Please consider making an investment. We won't let you down!
VLRM will do very well if it has found a way to get around all these regulatory issues as Binance were doing something similar where investors could buy small portions of stocks through tokens.
Binance’s stock tokens let users buy a fraction of publicly traded companies’ shares without paying commission fees. Stocks on offer included Apple, Coinbase, Microsoft, MicroStrategy and Tesla. Prices were settled in the company’s own dollar-pegged stablecoin, Binance USD.
Binance has been facing a growing crackdown from regulators around the world. Last month, Britain’s markets watchdog barred the firm from carrying out regulated services in the country, while Italy’s securities regulator on Thursday said Binance was not authorized to provide investment services to Italians.
Seems to be more scrutiny over the whole cryptocurrency sector by regulators after the below news...
Seems to be more scrutiny over the whole cryptocurrency sector by regulators after the below news...
Have put a little time into working out the current NAV of Gunsynd's portfolio so that we have a better idea if the SP is under or over valued currently. Hope this helps current and future investors in making an investment decision.
Listed Investments (£4,828,000)
£1,480,000 - Rincon
£1,450,000 - Rogue Baron
£1,114,000 - Eagle Mountain
£415,997 - Charger Metals Limited
£190,000 - DiscovOre
£124,500 - Empress Royalty
£53,347 - Pacific Nickel
Unlisted Investments (£440,000)
£265,000 - Low6
£125,000 - Anglo Saxony Mining
£50,000 - Media Tech SPAC
£5,268,000 - Current Total Investments Value
£1,297,166 - Current Cash Value
£6,565,166 - Current Total NAV
449,796,506 Total Shares in Issue
Fair value just taking into account the current assets NAV = 1.46p.
Cash Accumulated since 31st Jan 2021
£1,000,000 balance as of 31st Jan 2021 (stated in recent half-year report)
£454,166 - total received from exercised warrants since 31st Jan 2021
£501,000 - disposal of investments since 31st Jan 2021
Total Accumulated = £1,955,166
Cash Spent since 31st Jan 2021
£65,000 - 26th Feb 2021 - Additional Investment - Low6
£125,000 - 24th Mar 2021 - New Investment - Anglo Saxony Mining
£50,000 - 21st Apr 2021 - New Investment - Media Tech SPAC PLC
£200,000 - 28th Apr 2021 - New Investment - DiscovOre plc
£218,000 - 17th Jun 2021 - Investment in Charger Metals Limited
Total Invested = £658,000
Remaining Cash Remaining = £1,955,166 - £658,000 = £1,297,166
Gunsynd's holding of 2.5 million shares in Rincon is currently worth £1.14 million based on the current market bid price.
A drilling update at Oracle Ridge in Arizona, USA was published last Friday.
Gunsynd's holding of 8.9 million shares in Rincon is currently worth £1.48 million based on the current market bid price.
Rincon held a public presentation a few days ago where they provided information about current drills underway.
South Telfer Gold-Copper Project (Rincon 100%)
? +500km2 in Paterson Province
? 12km south & southwest along strike from World Class Telfer Gold Mine
? +50km of prospective & under-explored Telfer host geology
? Maiden 5,000m RC drilling programme underway Hasties Prospect
Laverton Gold Project (Rincon 100%)
? +30km2 in heart of Laverton Gold District (+25Moz gold endowment)
? Mt Margaret-Murrin Greenstone Belt
? 6km strike of under-explored & prospective BIF stratigraphy
? Recent air-core drilling identifies anomalous gold trends for follow-up
Kiwirrkurra Copper-Gold Project (Rincon 100%)
? +126km2 in West Arunta Orogen including Central Australian Suture
? First mover opportunity in underexplored region
? Prospective for Gold, and IOCG style Copper deposits
Quick update on the Rogue Baron investment...
Gunsynd had originally invested around £500,000 into Rogue Baron (formerly Human Brands).
3,000,000 shares were sold for £120,000 in an off-market transaction.
Meaning remaining invested equals £380,000.
21,543,563 remaining shares in Rogue Baron which at the current market bid price of 6.75p equals a total of £1.45 million.
Gunsynd also retains a balance of £111,464 of Convertible Loan Notes consisting of accrued interest
Shares are currently locked in until early next year and Rogue Baron have also applied to list in the US OTCQB market which will widen the investor base.
Rogue Baron has also released the below update a few days ago which announced record sales in their Washington DC bar.
Asides from their NAV in assets - they do have an operating business (media content and digital solutions provider) with well known brands (including Shell, Subway, BP, Nationwide Building Society, JD Sports, Weir, BMW, IKEA, and FIFA) which they could be looking into selling to raise further funds for their potential acquisition. Last year's revenue was impacted by the pandemic and was around £2.3 million but sounds like they are doing better this year...
"In light of the above developments and improved trading conditions the Board continues to consider divestment options for its main trading subsidiary, Immedia Broadcast Limited. Any proposed disposal would require shareholders' approval under AIM Rule 15."
The value will be in the potential acquisition (RTO) that IME are looking into and not the current NAV. There will be a reason why NED Mark Horrocks paid 25p for £400,000 in the placing at the beginning of this year. Hence some people will see value at these levels.
Asides from £2 million in cash, I believe that IME are still holding 318,740 shares in BOOM worth around £2.8 million
LONDON, U.K. AND PLANO, TX, U.S. (5 July 2021). Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that, as anticipated, it has signed its second US distribution agreement for its X-PLO2R™ portable oxygen concentrator ("POC") portfolio. This is the next stage in establishing US-wide distribution coverage as part of the Group's commercialisation strategy.
The distributor, located in the Midwest US, is a leading nationwide seller of supplemental oxygen and respiratory equipment. The distributor immediately issued its first purchase order with anticipated delivery of the X-PLO2R™ portable oxygen concentrator expected Q3 of this year.
As described in the Company's Admission Document, Belluscura's plan is to appoint distributors in the US to give US-wide coverage for the launch of the X-PLO2R™; and this is expected to occur in the second half of 2021 and into 2022.
Robert Rauker, CEO of Belluscura plc, said: "We continue to be very pleased with the reception the X-PLO2R™ portable oxygen concentrator is receiving from distributors and look forward to commercial launch in Q3 of 2021. We expect to announce additional distribution agreements in the very near future."
Interesting company and I have some questions on how the business concept would work. Does anyone understand how the below would be handled by VLRM? Would like to understand more before deciding if this is worth investing in.
One of the benefits that was explained in the CEO interview was that the platform would enable trading of global shares outside operating hours. A few questions on this...
1) Currently global brokers such as Interactive Brokers offer trading of shares from markets all around the world. They are also launching crypto trading this summer with their platform. Why would someone use the VLRM platform as opposed to a well established broker? Are there any benefits?
2) Why would someone buy the shares of a company through NFTs instead of buying the stock directly on the market? Surely this is an additional layer of risk? If you were to purchase $100,000 worth of Apple shares - would you buy the shares directly on the market of go through this NFT route? Especially if you are buying for long term and intend to collect dividends from the company.
3) Can anyone see China regulators allowing access to their markets with this technology considering they are very strict and have tight controls in place with their financial markets.
4) If they are to facilitate 24 hour trading of global stocks - how would that work? If the market is closed and I want to purchase $100,000 of a company?